About FDA
Population Assessment of Tobacco and Health (PATH) Study
Description: The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, longitudinal cohort study of approximately 59,000 non-users and users of tobacco products and those at risk for tobacco use across the United States. The sample will include approximately 42,000 adults 18 and up and 16,900 youth age 12-17. Survey data on tobacco use, attitudes, and health will be collected from adults, youth, and parents of youth and biospecimens (buccal cell, urine, and blood) will be collected from adults. PATH Study data will provide an evidence base for assessing and monitoring FDA’s current and future regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns. The PATH Study is conducted through an Interagency Agreement with the National Institute for Drug Abuse (NIDA) and the National Institutes for Health (NIH). Information is current as of November 30, 2012.
Briefing Status: ON TRACK
Prior Briefing Status: NOT YET STARTED
| Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
|---|---|---|---|
|
1. Request for Proposal (RFP) awarded by NIDA-NIH to contractor |
9/1/2011 |
Completed | 9/1/2011 |
|
2. Develop draft survey instruments |
7/1/2012 |
Completed | 7/1/2012 |
|
3. Prepare and submit Office of Management and Budget (OMB) package for field test and main study |
Summer 2012 |
Completed | 8/1/2012 |
|
4. Obtain OMB Approval for Field Test |
Fall 2012 |
Completed | 11/1/2012 |
|
5. Launch Field Test |
Fall 2012/Winter 2013 |
Completed | 12/5/2012 |
|
6. Complete Field Test analysis |
Winter/Spring 2013 |
Not Yet Started | |
|
7. Submit OMB materials for main study |
Summer 2013 |
Not Yet Started | |
|
8. Obtain OMB approval |
Summer 2013 |
Not Yet Started | |
|
9. Launch baseline data collection |
Fall 2013/Winter 2014 |
Not Yet Started | |
|
10. Complete data collection for baseline |
Fall 2014/Winter 2015 |
Not Yet Started | |
|
10. Complete data collection for baseline |
Fall 2014/Winter 2015 |
Not Yet Started | |
|
11. Launch first phase of follow up data collection |
Fall 2014/Winter 2015 |
Not Yet Started | |
|
12. Complete first manuscript of baseline results |
Fall 2015 |
Not Yet Started | |
|
13. Finalize restricted Use Data Set for baseline data |
Fall 2015 |
Not Yet Started | |
|
14. Complete first phase of follow up data collection |
Fall 2015/Winter 2016 |
Not Yet Started | |
|
15. Launch second phase of follow up data collection |
Fall 2015/Winter 2016 |
Not Yet Started | |
|
16. Publish First manuscript with first phase of follow up data |
Fall 2016 |
Not Yet Started | |
|
17. Finalize restricted Use Data Set from first phase of follow up data |
Fall 2016 |
Not Yet Started |
Key Projects Legend
| Milestone Status | Definition |
|---|---|
| Not Yet Started | Work for specific milestone has not yet been started. |
| Completed | Milestone and/or overall project is completed. |
| On Track | Milestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status. |
| On Hold | Milestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status. |
| Delayed | Milestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status. |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
